Although the 2017 KDIGO guidelines of CKD-MBD have recommended monitoring serum concentrations of calcium, phosphorus, and intact parathyroid hormone beginning in stage 3 CKD, our subsidiary analyses indicated that the risk prediction of these markers hinged upon sex and hypertension status. This evidence concerns the gene PTH and Hypertension.